Antithrombotic therapy after bioprosthetic aortic valve implantation: Warfarin versus aspirin, a randomized controlled trial

详细信息    查看全文

• 作者：Sulman Rafiq^a ; ^{sulman_raf@hotmail.com} ; Daniel Andreas Steinbr&uuml ; chel^a ; ^{dastpr@gmail.com} ; Nikolaj Bang Lilleø ; r^a ; ^{thomas.nikolaj.lilleoer@regionh.dk} ; Christian Holdflod Mø ; ller^a ; ^{christian.moeller.02@regionh.dk} ; Jens Teglgaard Lund^a ; ^{jlund@dadlnet.dk} ; Jens Juel Thiis^a ; ^{jens.juel.thiis@regionh.dk} ; Lars Kø ; ber^b ; ^{lars.koeber.01@regionh.dk} ; Peter Skov Olsen^a ; ^{peter.skov.olsen@regionh.dk}
• 关键词：AVR ; aortic valve replacement ; BAVR ; bioprosthetic aortic valve replacement ; CABG ; coronary artery bypass grafting ; CT ; computed tomography ; DVT ; deep vein thrombosis ; ECC ; extracorporeal circulation ; INR ; International Normalized Ratio ; MI ; myocardial infarction ; NOAC ; newer oral anticoagulants ; TCI ; transitory cerebral ischemia
• 刊名：Thrombosis Research
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：150
• 期：Complete
• 页码：104-110
• 全文大小：458 K
• 卷排序：150

文摘

Largest randomized trial testing warfarin versus aspirin after bioprosthetic aortic valve No difference in thromboembolic events between warfarin and aspirin Warfarin therapy associated with significantly more bleeding Difficult to maintain patients in therapeutic INR interval